Literature DB >> 9574781

Neutralizing mechanism of a monoclonal antibody against Japanese encephalitis virus glycoprotein E.

S Butrapet1, J Kimura-Kuroda, D S Zhou, K Yasui.   

Abstract

The neutralization of Japanese encephalitis virus (JEV) was studied using JEV-specific neutralizing (NT) monoclonal antibody (MAb) 503 that recognizes the envelope glycoprotein. Analysis using radiolabeled JEV and observations by confocal laser microscopy and electron microscopy indicated that the NT and protection activities of MAb 503 did not result from the prevention of the first step of JEV infection, binding of virus to the cell surface. Treatment with MAb 503 strongly inhibited JEV-induced cell fusion and internalization of JEV into the cells, and resulted in enhanced release of JEV-RNA from the cells. These observations suggested that the NT activity of MAb 503 is involved in the later steps of JEV infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574781     DOI: 10.4269/ajtmh.1998.58.389

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  The pathogenesis of spinal cord involvement in dengue virus infection.

Authors:  Jing An; De-Shan Zhou; Kazunori Kawasaki; Kotaro Yasui
Journal:  Virchows Arch       Date:  2003-04-15       Impact factor: 4.064

2.  Establishment of the 3rd national standard for lot release testing of the Japanese encephalitis vaccine (Nakayama-NIH strain) in Korea.

Authors:  Sunmi Lee; Hyungsil Moon; Min Gyu Kim; Do Keun Kim; Hye Joo Chung; Yong Keun Park; Ho Jung Oh
Journal:  Hum Vaccin Immunother       Date:  2016-02-18       Impact factor: 3.452

3.  A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.

Authors:  Bruce S Thompson; Bastiaan Moesker; Jolanda M Smit; Jan Wilschut; Michael S Diamond; Daved H Fremont
Journal:  PLoS Pathog       Date:  2009-05-29       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.